Home » Posts tagged 'alliance pharma'

Tag Archives: alliance pharma

Alan Green talks to Venture Life Group #VLG CCO Sharon Collins about the results of the groundbreaking COVID Mouthwash trial at Cardiff University.

Alan Green talks to Venture Life Group (AIM: VLG) CCO Sharon Collins about the results of the groundbreaking COVID Mouthwash trial at Cardiff University. Sharon also discusses the group progress to date in 2020, and summarises the current investment proposition for investors

Venture Life Group #VLG – CEO Jerry Randall discusses today’s interim results & trading update

Alan Green talks to Venture Life Group (VLG) CEO Jerry Randall about the company’s interim results.

Jerry goes through the numbers and commercial developments for the period, before discussing post period-end developments, including an independent study at Cardiff University on the effects on Dentyl Dual Action mouthwash on patients affected by COVID-19.

Jerry explains the resilience and adaptability of the Venture Life business model in countering the challenge of the COVID lockdown, and highlights how the group’s strong cash position will fund any future acquisitions.

Venture Life Group VLG – Trading Update July 20th 2020

Alan Green talks to Venture Life Group (VLG) CEO Jerry Randall about today’s trading update. Jerry provides an overview of the VLG offering, and then discusses the financial and commercial highlights in today’s statement. Looking forward Jerry covers VLG’s strong financial position, and how non-dilutive funding will be used for further acquisitions, some of which (subject to Covid restrictions), may arrive before Christmas 2020.

Jerry also provides key points for investors going forward.

1) Earnings growth, profitability and strong cashflow

2) Manufacturing capacity – following investment into the manufacturing and distribution, VLG can now increase it’s capacity by 50%.

3) Improving liquidity for shareholders. The appointment of N+1 Singer has improved liquidity and volumes in the market

Venture Life Group (AIM: VLG) – Alan Green talks to CEO Jerry Randall

Alan Green talks Jerry Randall, CEO of Venture Life Group (AIM: VLG). Jerry provides an overview of the company operating structure and strategy, and then covers today’s trading statement, going into detail on the very strong trading that will see the company ‘comfortably exceed market expectations’ for the year. Jerry covers the group’s commercial relationships and partners, provides detail on the strong funding position and provides an outlook for value inflection points going forward.

Ian Pollard – National Express Gearing Up For A Strong Christmas

National Express NEX has continued to see a good trading performance across all its divisions in October and November. In both the US and Spain early Christmas trading has been strong and advanced sales are higher then last year. Two small acqisitions have been completed, one in he states with 204 buses and the second in Madrid with 73 buses, each of which is expected to provide a return of 15 – 20% in line with company policy.

Elegant Hotels ELG  had received an approach from Melia Hotels  regarding a possible all cash offer for shares in Elegant but discussions have now been terminated and Melia will not be making any offer.

Alliance Pharma APH has agreed to acquire from Tyra Tech for an initial consideration of £13m, the worldwide rights to Vamousse which is an innovative consumer healthcare brand. The acquisition will be immediately earnings  enhancing.

My Sale Group MYSL will announce at today’s AGM that the current year has started well, revenue growth has accelerated compared to last year, gross margins are increasing and costs are being kept under control. Plans fr the year are ambitious but underlying profitability is growing in line with management expectations.

Palace Capital PCA is increasing its interim dividend for the 6 months to the 30th September, by 5.6%. The end September portfolio valuation showed a rise of 10.7%, profit before tax increased by 25.6% and adjusted earnings per share by 18.5%. Palace claims it has built a high quality portfolio, due to careful stock selection and is showing increasing growth both in income and in capital value.

Cora Gold Limited CORA has commenced a six month drill pogramme at its Sanankora Gold discovery in southern Mali. The pogramme is expected to be completed during he second quarter of 2018.

Beachfront villas & houses for sale in Greece    http://www.hiddengreece.net

Galliford Try Blames Caution On Impact Of Politicians !!

Galliford Try GFRD When the best that a company can find to say about its annual results is that they show a strong underlying performance, then you know that something went wrong. Otherwise it would be claiming a strong financial performance, and that  is something which Galliford can not claim. Profit before tax for the year to 30th June fell by 57% and earnings per share by 55%, even though it had the benefit of robust market conditions. The financial performance for the year was impacted by legacy costs in Construction – so that’s alright then ? Can’t be laid at the door of management, that sort of thing, can it ? The shareholders are kept happy with a 17% rise in fully year dividends. To cover itself for the future it is even reduced to blaming the politicians and a board of directors can not sink much lower than that. It is cautious about the future it says, because of the impact of current political uncertainty. That does not seem to be a worry or even a concern for other house builders and in any event politicians and the uncertainty they create have been with us since the dawn of time.

Dunelm Group DULM went ex growth in the year to 1st July with a fall of 0.5% in like for like revenue and profit before tax down by 28.3%, as it tried to cope with a challenging and subdued Homeware and Furniture Market. EBITDA fell by 7.8% and earnings per share  by 28% from 50.3p to 36.1p. The ordinary dividend is to be raised by 3.6%. Things improved with the start of the new financial year and sales growth in the first two months is described as being good. What exactly “good’ means in round figures is for some reason being kept a closely guarded secret.

Adv. Medical Solutions AMS continues to go from strength to strength as profit before tax for the six months to 30th June rose by 27% and the interim dividend is increased by 17%. Group revenues grew by 8% at constant currency rates with US revenue rising by 52% and sales of Liquiband strong in all its markets. the company is optimistic about future organic growth.

Surgical Innovations SUN produced strong growth in both revenue and profits in the half year to the 30th June. Revenue rose by 14.1% and last years first half loss of £0.6m was turned into a profit of £0.3m. both sets of figures being at the upper end of the board’s expectations. The acquisition of Elemental Healthcare on the 1st August is regarded as being transformational for the company.

Alliance Pharma APH is increasing its interim dividend by 10% following strong growth from its international brands and an 8% rise in revenue. The integration of Sinclair Pharma has now been completed and “bolt on” acquisitions are now being pursued.

 Villas & houses for sale in Greece  – visit;   http://www.hiddengreece.net

 

Weak Pound Is Not A Crutch For Weak Management

Experian EXPN produced revenue growth of 6% in the quarter to the 30th June. On an organic basis the growth was 4% and for business to business on an organic basis it was a sturdy 7%. But Experian is yet another company  producing appalling figures for the UK which suffers more and more from the devastation wreaked on the country by politicians who regard a weak currency as the greatest benefit they can give to the nation and deliberately pursue policies aimed at destroying the value of the pound. Revenue in the UK & Ireland fell by 13% during t he quarter and even at constant exchange rates there was a decline of 3%.

Royal Mail RMG CEO Moya Green believes that a 1% revenue rise in the three months to the 25th June can fairly be described as “another strong performance” in GLS. Total letter revenue fell by 4% but she remains silent as to whether that is weak or strong. Parcels did better with revenue up by 3% on volume up by 5%. Star performer was Royal Mail Tracked Services with growth of 39%.  Despite miserable figures in some areas, she claims that the overall trading performance for the quarter was good.

Dairy Crest DCG Volume sales for Dairy Crests four key brands in the quarter to 30th June are 7% ahead of last year, Cathedral City leading the way with a rise of 15%. There is a cloud on the horizon in the form of increased input costs, which have increased substantially for the butter business and led to a reduction in the promotion of Country Life in order to try and save money. Overall however trading for the quarter has been in line with expectations.

Ideagen plc IDEA is increasing its final dividend to 0.142p per share making a total increase for the year of 15%. Revenue for the year to 30th June rose by 24%, profit before tax by 22% and underlying organic growth by 10%. Trading since the year end has been robust with strong demand from new customers.

Alliance Pharma plc APH Sales in the six months to the end of June grew by 8% with help from a weak pound adding £2.6m part of which was offset by higher import costs. The cp,[any’s international growth brands have been successful with sales growth of 50% or more.

 

Villas & houses for sale in Greece  – visit;   http://www.hiddengreece.net

Flybe Full of Grumbles

Flybe FLYB The airline industry is in for a rough time if Flybe’s grumbles are anything to go by. On the other hand reading todays update for the quarter to the end of March does read a bit like a management clutching at straws. It claims to have suffered from airline overcapacity, coupled with weak demand in an uncertain consumer environment and price competition from railways. to counter these problems it has reduced its year on year seat capacity growth to 10%.  Passenger revenue rose by 9.8% compared to 13.5% for quarter 3. The fleet will be reduced by the return of all 6 end of lease aircraft in the second half of the financial year. Summer trading is in line with expectations.

Alliance Pharma APH The integration of 27 products acquired in December 2015 from Sinclair Pharma has been completed without a hitch, effectively doubling the size of APH. Confirmation is provided by the results fore the year to 31st December which saw revenue and EBITDA both grow by 102%, with pre tax profit following suite at 103%. The final dividend is increased by 10% making the total rise for the year, also 10%. APH’s philosophy, with its “can do” approach, is to become the rising star of European specialty pharma. The directors intend to maintain a progressive dividend policy.

TUI Ag TUI expects at least 10% growth in underlying EBITA  for the current financial year. Winter revenue rose by 9% and customer numbers were up by 5%, with 97% of the winter programme sold. 48% of the summer programme has been sold so far, with revenue also up by 9% and customers by 4%

Johnston Press JPR saw sign of an improving trend emerge in quarter 4 which has continued into the new financial year, with a rise in the circulation figures of its key titles. for the year to the end of December adjusted revenue fell by 6% but with quarter 4 showing a rise of 1%, as the sector continued to suffer from revenue volatility and structural change. 2015’s statutory like for like profit before tax of £2.2m was turned into a loss of £300m for 2016 and basic earnings per share fell from 10p to a loss of 234p per share.

Villas & Houses For Sale in Greece; http://www.hiddengreece

Source

Cello Is a Bowed String Instrument And Not A Fiddle

Alliance Pharma APH has more than doubled revenue and pre tax profits in the 6 months to the 30th June and is increasing the interim dividend by by 10%. Revenue rose by 104% including sales of ex Sinclair products whilst profit before tax rose by 113% and basic earnings per share by 25%. The share price has been showing some signs of strength since the end of June with a rise from 42p to 51p, approaching its previous all time high of 60p.

Advanced Medical Solutions AMS claims to be in robust health, with strong financial growth for the half year to 30th June. LiquiBand continues to perform strongly in the US, producing a rise in revenue of 83% and further gains in market share.The interim dividend is being increased by 20% after a rise in revenue of 20% and a 13% rise in profit before tax. revenue has been helped by currency fluctuations. The share price as grown almost without interruption from 55p at the start of 2013, to its present 227p.

Dunelm DNLM Put in a strong performance for the year to 27th June and continuing a record of ever increasing sales and profits over the last 10 years. The final dividend is to be increased by 19.1% bringing full year dividends to 25.1p, a rise of 16.7%, in addition to which there has been a special distribution of 31.5p per share.Profit before tax rose by 6.2%, basic earnings per share by 7.4% and revenues by 7.1%.

Galliford Try GFRD produced another set of record results for the year to 30th June, but being a housebuilder, that is expected. Profit before tax rose by 18% and the full year dividend payments are up by 21%. Linden Homes saw completions rise from 2769 to 3078 which I make out to be a rise of 11% but revenue was up by only 8%.  Housebuilders do not give discounts, not yet at least but did the odd incentive become necessary during the course of the year?

Cello CLL is increasing its interim dividend by 19% following a statutory loss of £0.8m and a statutory basic loss of 1.8p per share, for the 6 months to 30th June. Last year it made a first half profit of £1.9m so this year has seen quite a turn round. Obviously the board must have put its thinking cap on as to how to justify the dividend hike and  to do so it came up with a new formula.  As from now dividends will be equal to 40% of headline earnings per share, that being one of the few statistics showing a positive outcome, even if at  3.54p they were lower than last years 3.61p. Nice for the shareholders, anyway. And to make sure that no one is confused with the half year results, the company makes it clear that “Headline operating margin is defined as headline operating profit as a percentage of segmental gross profit“. Can’t get fairer than that, can it?

Beachfront Property For Sale In The Greek Islands – visit;   http://www.hiddengreece.net

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.